![]() |
Akso Health Group (AHG) DCF Valuation
CN | Financial Services | Financial - Credit Services | NASDAQ
|

- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Akso Health Group (AHG) Bundle
Designed for accuracy, our (AHG) DCF Calculator enables you to evaluate Akso Health Group's valuation using real-world financial data, offering complete flexibility to modify all essential parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 11.4 | 1.8 | 6.3 | 13.2 | 2.4 | 2.6 | 2.8 | 3.1 | 3.3 | 3.6 |
Revenue Growth, % | 0 | -84.65 | 259.62 | 108.86 | -81.68 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 |
EBITDA | -18.8 | -2.1 | -3.3 | -14.2 | -8.5 | -2.4 | -2.6 | -2.8 | -3.0 | -3.3 |
EBITDA, % | -164.37 | -118.04 | -51.66 | -108.09 | -352.06 | -90.33 | -90.33 | -90.33 | -90.33 | -90.33 |
Depreciation | .1 | .0 | .0 | .0 | .1 | .0 | .0 | .0 | .1 | .1 |
Depreciation, % | 1.05 | 0.86391 | 0.29139 | 0.13951 | 5.73 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 |
EBIT | -18.9 | -2.1 | -3.3 | -14.3 | -8.6 | -2.4 | -2.6 | -2.8 | -3.0 | -3.3 |
EBIT, % | -165.42 | -118.9 | -51.95 | -108.23 | -357.78 | -90.39 | -90.39 | -90.39 | -90.39 | -90.39 |
Total Cash | 10.9 | 15.1 | 21.9 | 7.9 | 85.2 | 2.4 | 2.6 | 2.8 | 3.0 | 3.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 31.9 | 10.4 | 20.0 | 7.7 | .0 | 1.9 | 2.0 | 2.2 | 2.4 | 2.6 |
Account Receivables, % | 278.95 | 594.91 | 316.9 | 58.39 | 0 | 71.68 | 71.68 | 71.68 | 71.68 | 71.68 |
Inventories | -38,996.2 | -14.4 | 7.8 | 1.7 | .2 | -.4 | -.5 | -.5 | -.5 | -.6 |
Inventories, % | -341023.32 | -818.98 | 123.53 | 12.79 | 7.92 | -15.86 | -15.86 | -15.86 | -15.86 | -15.86 |
Accounts Payable | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Expenditure | -.3 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | -2.75 | 0 | -0.07702312 | 0 | 0 | -0.5655 | -0.5655 | -0.5655 | -0.5655 | -0.5655 |
Tax Rate, % | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 |
EBITAT | -20.1 | -2.1 | -3.3 | -14.3 | -9.0 | -2.4 | -2.6 | -2.8 | -3.0 | -3.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 38,944.0 | -38,962.5 | -35.0 | 4.1 | .3 | -3.6 | -2.7 | -2.9 | -3.1 | -3.4 |
WACC, % | 4.95 | 4.95 | 4.95 | 4.95 | 4.95 | 4.95 | 4.95 | 4.95 | 4.95 | 4.95 |
PV UFCF | ||||||||||
SUM PV UFCF | -13.6 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -3 | |||||||||
Terminal Value | -117 | |||||||||
Present Terminal Value | -92 | |||||||||
Enterprise Value | -106 | |||||||||
Net Debt | -85 | |||||||||
Equity Value | -21 | |||||||||
Diluted Shares Outstanding, MM | 47 | |||||||||
Equity Value Per Share | -0.44 |
What You Will Get
- Editable Forecast Inputs: Effortlessly modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Akso Health Group’s financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life AHG Financials: Pre-filled historical and projected data for Akso Health Group (AHG).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Akso’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Akso’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template with Akso Health Group’s (AHG) data included.
- Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including Akso Health Group’s (AHG) intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose This Calculator for Akso Health Group (AHG)?
- Accurate Data: Up-to-date Akso Health Group financials provide trustworthy valuation outcomes.
- Customizable: Tailor essential parameters like growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Easy-to-navigate design and clear instructions cater to users of all experience levels.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for investment analysis in the health sector.
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within healthcare organizations.
- Consultants and Advisors: Deliver precise valuation insights for Akso Health Group (AHG) to clients seeking healthcare investments.
- Students and Educators: Utilize real-world healthcare data to practice and instruct on financial modeling techniques.
- Health Industry Enthusiasts: Gain insights into the valuation processes of companies like Akso Health Group (AHG) in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Akso Health Group (AHG) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Akso Health Group (AHG).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.